Target intelligence / Profile preview

Spleen tyrosine kinase-Phosphoinositide 3-kinase-Nuclear factor kappa B signaling pathway (Syk-PI3K-NF-κB pathway)

Target
Syk-PI3K-NF-κB pathway
Molecular classification
Signaling pathway, Kinase cascade, Transcription factor signaling
01

Overview

The Spleen tyrosine kinase-Phosphoinositide 3-kinase-Nuclear factor kappa B (Syk-PI3K-NF-κB) signaling pathway is a critical intracellular cascade that mediates the activation and maturation of dendritic cells (DCs) in response to various stimuli, particularly through C-type lectin receptors (CLRs) like Dectin-1 and Dectin-2 [PMID: 17448156, 21525984]. Upon ligand binding, Syk is recruited to phosphorylated immunoreceptor tyrosine-based activation motifs (ITAMs), triggering downstream activation of PI3K [PMID: 19234452]. This cascade ultimately leads to the activation and nuclear translocation of NF-κB, which drives the expression of pro-inflammatory cytokines and costimulatory molecules necessary for T-cell priming [PMID: 23601688]. This pathway plays a pivotal role in orchestrating innate and adaptive immune responses against fungal and bacterial pathogens [PMID: 28978534]. Pharmacological targeting of individual components, such as Syk or PI3K, is a therapeutic strategy used to modulate immune responses in inflammatory, autoimmune, and hematological disorders [PMID: 30333114].

Other names
Syk-PI3K-NF-kappaB pathwayDendritic cell activation pathwayCLR-Syk signaling cascadeSyk-dependent signaling in dendritic cells
02

Mechanism of action

Inhibition of Spleen tyrosine kinase (Syk) activity, inhibition of Phosphoinositide 3-kinase (PI3K) isoforms, or inhibition of the NF-kappaB activation pathway to modulate immune cell function.

03

Biological functions

Immune responseSignal transductionCytokine productionDendritic cell maturationInnate immunity
04

Disease associations

InflammationAutoimmune diseaseInfectionCancer
05

Safety considerations

ImmunosuppressionIncreased risk of opportunistic infectionsGastrointestinal toxicityNeutropeniaHepatotoxicity
06

Interacting drugs

Fostamatinib

4 more in the full profile.

07

Biomarkers

Phospho-Syk levelsPhospho-Akt levelsIL-6 secretionTNF-alpha secretionNF-kappaB p65 nuclear translocation

Beyond the preview

Go deeper on Spleen tyrosine kinase-Phosphoinositide 3-kinase-Nuclear factor kappa B signaling pathway (Syk-PI3K-NF-κB pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spleen tyrosine kinase-Phosphoinositide 3-kinase-Nuclear factor kappa B signaling pathway (Syk-PI3K-NF-κB pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call